Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
International journal of clinical oncology
AGE WELL GHK-Cu GHK-Cu, or copper peptides, are a combination of tripeptide Glycyl-L-Histidyl-L-Lysine and copper ions
Perhaps most intriguingly, emerging research suggests potential benefits for non-alcoholic fatty liver disease (NAFLD) and diabetic kidney disease, indicating systemic metabolic optimization rather than targeted symptom management
Moreover, these compounds may potentially contribute to a metabolism boost
They may also be used for diabetes, hypogonadism, and metabolic disorders